Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > Lettus pray
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(3)
•••
Comment by dudsywowon May 10, 2016 3:15pm
93 Views
Post# 24858965

RE:RE:Lettus pray

RE:RE:Lettus prayLats, try to be more subtle... like Donnatol, you're losing your efficacy.


Lattice wrote:
dudsywow wrote: Pray ....  !
that the Senate didn't read the email to Mike Pearson about the Covis portfolio that Concordia ended up acquiring in March

"U.S. Investigates Drugmaker Contracts with Pharmacy-Benefit Managers"
The Wall Street Journal
May 10, 2016
By Peter Loftus

And now the Valeant infection spreads further.




 



<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities